Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lithospermum officinale is a perennial herb native to Eurasia and widely known as "gromwell" or "European stoneseed."[2][5] Traditionally employed in ethnomedicine across Europe, Asia, and North America, all plant parts are used for various indications, most notably as a diuretic and for the management of urinary system disorders, bladder stones, arthritis, febrile conditions, and as a sedative.[1][2][5][6] The seeds are ground into a powder for bladder stones and arthritis; leaves are used as a sedative; decoctions of root and twigs address eruptive diseases such as measles and smallpox.[2][1][5] Phytochemical investigations reveal alkaloids (including pyrrolizidine alkaloids), quinones (alkannin, shikonin), phenolics (rosmarinic, lithospermic, caffeic, chlorogenic acids), flavonoids (rutin, luteolin-7 beta-glucuronide), and lipids (γ-linolenic, stearidonic acids, Δ^5^-avenasterol).[3][4] Documented effects include anti-inflammatory, antioxidant, diuretic, antimicrobial, wound healing, antithyrotropic, vasoprotective, neuroprotective, and contraceptive activities, with some compounds reported hepatotoxic (lycopsamine, echimidine).[3][4][5] Preclinical research demonstrates inhibition of thyroid-stimulating hormone (TSH) action and pituitary gonadotropins (FSH, LH), and positive effects in models of burn wound healing, neuroinflammation, and hormone regulation.[3][4] Used mainly as a dietary supplement or herbal medicine; not approved as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lithospermum officinale.